Pro-Dex, Inc. (PDEX)

Pro-Dex, Inc.'s stock price has increased significantly by 44.10% over the past six months. Key events include the announcement of the acquisition of Advanced Precision Machining on February 12, 2026, and the announcement of Fiscal 2026 Second Quarter and Six-Month Results on January 29, 2026, reporting an EPS of $0.66 and revenue of $18.66 million. In March, the stock price experienced fluctuations, reaching a high of $51.820 and a low of $43.010, and was up 5.03% for the month as of March 21, 2026. However, on March 20, 2026, the stock was down 5.02% from its previous closing price. There was also a downward revision in FY25 estimates for revenue and EPS.

Detailed information regarding the demand seasonality for Pro-Dex, Inc.'s products and services is not explicitly available in the provided search results, although there is a mention of "PDEX Seasonality" to identify seasonal patterns in monthly returns.

Pro-Dex, Inc. specializes in the design, development, manufacture, and sale of powered surgical instruments for medical device OEMs globally, operating within the Healthcare sector. Its major products include autoclavable, battery-powered, and electric multi-function surgical drivers and shavers, primarily utilized in orthopedic, thoracic, and craniomaxillofacial surgical procedures. The company also provides engineering, quality, and regulatory consulting services, and manufactures rotary air motors for various industries, with products used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations.

Pro-Dex, Inc. is headquartered in Irvine, California, and maintains two facilities in California, located in Irvine and Tustin. The company offers its outsourcing services nationwide and internationally, selling its medical device products to OEMs worldwide.

Pro-Dex's products are known for their durability and long lifespan. Their screwdriver products, specifically those used in cranial and thoracic applications, are recognized for their unique "adaptive torque limiting" technology. The company has a history of successful collaborations with major medical and dental product providers. No specific events negatively impacting Pro-Dex, Inc.'s brand reputation in the past year were identified.

Pro-Dex, Inc.'s ownership is a mix of institutional, insider, and public/individual investors. Major institutional shareholders include BlackRock, Inc., Vanguard Group Inc, and Dimensional Fund Advisors Lp. Nicholas Swenson is a significant individual owner, holding 31.4% of the company's shares. Institutional investors hold approximately 12.50% to 19.91% of the stock, insiders hold about 45.57%, and public companies and individual investors hold between 7.41% and 34.53%.